Overview
Vania Herbillon practices in Lyon, France. Ms. Herbillon is rated as an Advanced expert by MediFind in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Her top areas of expertise are Benign Rolandic Epilepsy, Narcolepsy, Drowsiness, and Attention Deficit Hyperactivity Disorder (ADHD).
Her clinical research consists of co-authoring 26 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 12 articles in the study of Attention Deficit Hyperactivity Disorder (ADHD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Attention Deficit Hyperactivity Disorder (ADHD)
- Benign Rolandic EpilepsyMs. Herbillon isAdvanced. Learn about Benign Rolandic Epilepsy.
- DrowsinessMs. Herbillon isAdvanced. Learn about Drowsiness.
- NarcolepsyMs. Herbillon isAdvanced. Learn about Narcolepsy.
- Experienced
- Absence SeizureMs. Herbillon isExperienced. Learn about Absence Seizure.
- EpilepsyMs. Herbillon isExperienced. Learn about Epilepsy.
- Epilepsy Juvenile AbsenceMs. Herbillon isExperienced. Learn about Epilepsy Juvenile Absence.
- Generalized Tonic-Clonic SeizureMs. Herbillon isExperienced. Learn about Generalized Tonic-Clonic Seizure.
- NeurofibromatosisMs. Herbillon isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Ms. Herbillon isExperienced. Learn about Neurofibromatosis Type 1 (NF1).